(Q38127375)

29 August 2017

title

The role of microRNAs in lung cancer progression (English)

1 reference

29 August 2017

1 reference

1 reference

Wen-Cheng Zhang

1

1 reference

29 August 2017

Jinbo Liu

series ordinal

2

1 reference

29 August 2017

Xiangying Xu

series ordinal

3

1 reference

29 August 2017

Guangshun Wang

series ordinal

4

1 reference

29 August 2017

publication date

8 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

30

1 reference

29 August 2017

issue

3

1 reference

29 August 2017

page(s)

675

1 reference

29 August 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNAs and genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

The novel miR-7515 decreases the proliferation and migration of human lung cancer cells by targeting c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Epigenetic regulation of miR-212 expression in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Serum microRNA biomarkers for detection of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0675-8

miR‑133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP‑14.

21 January 2018

1 reference

12 December 2020

Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis

1 reference

12 December 2020

Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

1 reference

12 December 2020

DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer

1 reference

12 December 2020

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients

1 reference

12 December 2020

Genetic variants of miRNA sequences and non-small cell lung cancer survival

1 reference

12 December 2020

Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer

1 reference

12 December 2020

10.1007/S12032-013-0675-8

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1023315358

0 references

1 reference